MedTrace Logo

Botulinum Toxin A Associated Costs in the Treatment of Upper Limb Spasticity Post Stroke

NCT02384330 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 57

Last updated 2019-01-07

No results posted yet for this study

Summary

This study aims to estimate the costs of botulinum toxin A utilization in standard practice for the treatment of upper limb spasticity post-stroke in Portugal.

It will consider the three most used locally available brands of botulinum toxin A which show similar efficacy and safety profiles thus making it relevant to understand if choosing between one or another brand can depend directly on economic factors.

The study will estimate direct and indirect drug-associated costs as determinant variables for the price of each drug and the standard drug dose used in clinical practice.

Conditions

  • Upper Limb Spasticity Post-Stroke

Sponsors & Collaborators

Principal Investigators

  • Ipsen Medical Director · Ipsen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2017-03-16
Completion
2017-03-16

Countries

  • Portugal

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02384330 on ClinicalTrials.gov